Cargando…
Drug‐eluting bead chemoembolization for the treatment of nonresectable hepatic carcinoma in dogs: A prospective clinical trial
BACKGROUND: Effective treatment options for nonresectable hepatic carcinoma (HC) in dogs are limited. HYPOTHESIS/OBJECTIVE: Objectives were to report outcomes, complications, and tumor responses via computed tomography (CT) assessment after drug‐eluting bead transarterial chemoembolization (DEB‐TACE...
Autores principales: | Rogatko, Cleo P., Weisse, Chick, Schwarz, Tobias, Berent, Allyson C., Diniz, Marcio A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons, Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8162590/ https://www.ncbi.nlm.nih.gov/pubmed/33955600 http://dx.doi.org/10.1111/jvim.16109 |
Ejemplares similares
-
Pharmacokinetic study comparing doxorubicin concentrations after chemoembolization or intravenous administration in dogs with naturally occurring nonresectable hepatic carcinoma
por: Samuel, Nina, et al.
Publicado: (2022) -
Endoscopic laser‐ablation for the treatment of orthotopic and ectopic ureteroceles in dogs: 13 cases (2008‐2017)
por: Rogatko, Cleo P., et al.
Publicado: (2019) -
Evaluation of hepatic tumor portal perfusion using mesenteric angiography: A pilot study in 5 dogs
por: Goode, Kelsey, et al.
Publicado: (2018) -
Stenting of the caudal aorta and aortic trifurcation for the treatment of thrombosis in 7 dogs
por: Gavin, Kelly A., et al.
Publicado: (2022) -
Prospective evaluation of an indwelling esophageal balloon dilatation feeding tube for treatment of benign esophageal strictures in dogs and cats
por: Tan, Desmond K., et al.
Publicado: (2018)